Education
About Us
Working with TipRanks
Follow Us
Medical Developments International Limited (AU:MVP)
ASX:MVP
MVP Stock Chart & Stats
AU$0.54
<AU$0.01(1.18%)
At close: 4:00 PM EST
AU$0.54
<AU$0.01(1.18%)
Day’s Range― - ―
52-Week RangeAU$0.40 - AU$0.94
Previous CloseN/A
Volume7.44K
Average Volume (3M)118.82K
Market Cap
AU$60.84M
Enterprise ValueAU$46.17M
Total Cash (Recent Filing)AU$17.84M
Total Debt (Recent Filing)AU$1.99M
Price to Earnings (P/E)540.0
Beta1.57
Next Earnings
Feb 19, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding112,658,325
10 Day Avg. Volume79,692
30 Day Avg. Volume118,816
Financial Highlights & Ratios
PEG Ratio-6.86
Price to Book (P/B)1.17
Price to Sales (P/S)1.65
P/FCF Ratio-132.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.85Price Target Upside57.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medical Developments International Limited News
MVP FAQ
What was Medical Developments International Limited’s price range in the past 12 months?
Medical Developments International Limited lowest share price was AU$0.40 and its highest was AU$0.94 in the past 12 months.
What is Medical Developments International Limited’s market cap?
Medical Developments International Limited’s market cap is AU$60.84M.
When is Medical Developments International Limited’s upcoming earnings report date?
Medical Developments International Limited’s upcoming earnings report date is Feb 19, 2026 which is in 60 days.
How were Medical Developments International Limited’s earnings last quarter?
Medical Developments International Limited released its earnings results on Aug 20, 2025. The company reported -AU$0.002 earnings per share for the quarter, beating the consensus estimate of -AU$0.011 by AU$0.009.
Is Medical Developments International Limited overvalued?
According to Wall Street analysts Medical Developments International Limited’s price is currently Undervalued.
Does Medical Developments International Limited pay dividends?
Medical Developments International Limited pays a Semiannually dividend of AU$0.019 which represents an annual dividend yield of N/A. See more information on Medical Developments International Limited dividends here
What is Medical Developments International Limited’s EPS estimate?
Medical Developments International Limited’s EPS estimate is <0.01.
How many shares outstanding does Medical Developments International Limited have?
Medical Developments International Limited has 112,658,325 shares outstanding.
What happened to Medical Developments International Limited’s price movement after its last earnings report?
Medical Developments International Limited reported an EPS of -AU$0.002 in its last earnings report, beating expectations of -AU$0.011. Following the earnings report the stock price went down -3.125%.
Which hedge fund is a major shareholder of Medical Developments International Limited?
Currently, no hedge funds are holding shares in AU:MVP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medical Developments International Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.85 (57.41% Upside)
AU$0.85 (57.41% Upside)
Blogger Sentiment
Bullish
AU:MVP Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$89.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
60.67%
12-Months-Change
Fundamentals
Return on Equity
0.19%
Trailing 12-Months
Asset Growth
10.89%
Trailing 12-Months
Company Description
Medical Developments International Limited
Medical Developments International Limited (MVP) is a specialized healthcare company based in Australia, focusing on the development and commercialization of innovative medical products and devices. The company operates primarily in the sectors of anesthetics, pain management, and respiratory care. MVP's core products include the Penthrox® inhalation anesthetic, designed for emergency and outpatient procedures, and various other healthcare solutions aimed at improving patient outcomes and enhancing procedural efficiency.
MVP Stock 12 Month Forecast
Average Price Target
AU$0.85
▲(57.41% Upside)
Technical Analysis
Little Green Pharma Ltd.
―
Bod Australia Ltd
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―
Cronos Australia Ltd.
―
Options Prices
Currently, No data available
---